Status:
UNKNOWN
Effectiveness Of The Pericapsular Nerve Group (PENG) Block In Hip Surgery
Lead Sponsor:
Aydin Adnan Menderes University
Conditions:
PENG Block
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The target population of hip surgery is usually the elderly patients with systemic comorbidity. Especially hip fractures are common in society and cause high morbidity and mortality for geriatric pati...
Eligibility Criteria
Inclusion
- Patients with written informed consent
- Patients over 18 years old
- Patients with ASA score I-II-III
- Patients performed spinal anesthesia for surgery
Exclusion
- Patients without written informed consent
- Patients with ASA score IV and above
- Patients who cannot be communicated
- Patients with infection at the block site
- Patients with coagulation disorders
- Patients not suitable for spinal anesthesia
- Patients with liver and kidney failure
- Patients who are allergic to the drugs used
- Patients with major complications during the operation
Key Trial Info
Start Date :
October 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2023
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT05997940
Start Date
October 1 2022
End Date
September 1 2023
Last Update
August 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Adnan Menderes University Faculty of Medicine
Aydin, Turkey (Türkiye)